From the latest mRNA vaccines to drug delivery systems, nanoparticles are increasingly popular therapeutic tools. Nanoparticles are versatile nano-sized vessels that shuttle small-molecule drugs, peptides, proteins, and nucleic acids to targeted sites in the body. For many scientists, how to leverage this cutting-edge technology remains a mystery. In this roundtable discussion, a panel of experts will discuss key considerations for manufacturing nanoparticle therapeutics.
Topics to be covered
- The nanoparticle manufacturing pipeline
- Nanoparticle types and utilities
- Regulatory and GMP considerations
- Scaling up nanoparticle production
Wednesday, September 7th, 2022 | 11:00 AM - 12:00 PM Eastern Time
This webinar will be available to view live and on demand.
Speakers
Robert Proulx
President and CEO
Imagion Biosystems
Tom Darlington, PhD
VP Operations & Quality
Fortis Life Sciences
Rondii Lynberg
Director of Quality Assurance & Regulatory Compliance
Fortis Life Sciences